Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GAA | P10253 | 1/20 | 0.76 |
| ▸ | RAB9A | P51151 | 1/20 | 0.76 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.75 |
| ▸ | LMNA | P02545 | 1/20 | 0.75 |
| ▸ | GLA | P06280 | 1/20 | 0.75 |
| ▸ | CTSL | P07711 | 3/20 | 0.70 |
| ▸ | ATM | Q13315 | 2/20 | 0.65 |
| ▸ | THRB | P10828 | 1/20 | 0.63 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.63 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.63 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.63 |
| ▸ | CTSS | P25774 | 1/20 | 0.62 |
| ▸ | CTSK | P43235 | 1/20 | 0.62 |
| ▸ | POLB | P06746 | 1/20 | 0.62 |
| ▸ | ACE | P12821 | 2/20 | 0.61 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.58 |
| ▸ | TACR3 | P29371 | 1/20 | 0.57 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.57 |
| ▸ | PKM | P14618 | 1/20 | 0.57 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2461492 | 1.00 | GAA (0.76) | GAARAB9AALDH1A1LMNAGLA | |
| SCHEMBL31206887 | 1.00 | GAA (0.76) | GAARAB9AALDH1A1LMNAGLA | |
| SCHEMBL4369272 | 0.94 | GAA (0.69) | GAARAB9AALDH1A1LMNAGLA | |
| SCHEMBL13669573 | 0.94 | GAA (0.69) | GAARAB9AALDH1A1LMNAGLA | |
| SCHEMBL14733433 | 0.93 | GAA (0.67) | GAARAB9AALDH1A1LMNAGLA | |
| SCHEMBL16515824 | 0.93 | GAA (0.67) | GAARAB9AALDH1A1LMNAGLA | |
| SCHEMBL13525006 | 0.92 | GAA (0.70) | GAARAB9AALDH1A1LMNAGLA | |
| SCHEMBL4175147 | 0.91 | GAA (0.73) | GAARAB9AALDH1A1LMNAGLA | |
| SCHEMBL3928165 | 0.91 | LNPEP (0.67) | GAARAB9AALDH1A1LMNAGLA | |
| SCHEMBL3928164 | 0.91 | LNPEP (0.67) | GAARAB9AALDH1A1LMNAGLA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 56 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4684030-A2 | METHOD OF DEPROTECTING AT LEAST ONE D-AMINO ACID AND/OR D-AMINO ACID DERIVATIVE PROTECTED FUNCTIONAL GROUP | Martin-Luther-Universität Halle-Wittenberg (DE) | 2026-01-28 | — | — | EP | disclosed |
| WO-2024227957-A2 | METHOD OF DEPROTECTING AT LEAST ONE D-AMINO ACID AND/OR D-AMINO ACID DERIVATIVE PROTECTED FUNCTIONAL GROUP | Martin-Luther-Universität Halle-Wittenberg (DE) | 2024-11-07 | — | — | WO | disclosed |
| US-20230040081-A1 | VACCINIA VIRAL POLYMERASE-MEDIATED VIRAL REPLICATION | IMMUNOLUX INTERNATIONAL CORP. | 2023-02-09 | — | — | US | disclosed |
| US-9243028-B2 | Facile amide formation via S-nitroso thioacid intermediates | WASHINGTON STATE UNIVERSITY (US) | 2016-01-26 | — | — | US | disclosed |
| US-9243028-B2 | Facile amide formation via S-nitroso thioacid intermediates | WASHINGTON STATE UNIVERSITY (US) | 2016-01-26 | — | — | US | disclosed |
| CN-102002063-B | The dipeptide boronic acid that one class carboxylic acid and beta amino acids form and ester compound, preparation method and its usage | JIANGSU SIMCERE PHARMACEUTICAL RESEARCH COMPANY LIMITED (CN) | 2015-07-29 | — | — | CN | disclosed |
| EP-2141142-B1 | METHOD FOR PRODUCING ALCOHOL BY HYDROGENATING LACTONE OR CARBOXYLIC ACID ESTER IN LIQUID PHASE | TAKASAGO PERFUMERY CO LTD (JP) | 2015-03-04 | — | — | EP | disclosed |
| CN-103721690-A | N-ferrocenyl (benzoyl)-phenylalanine methyl ester bonded silica gel stationary phase as well as preparation method and application thereof | UNIV ZHENGZHOU | 2014-04-16 | — | — | CN | disclosed |
| CN-103721690-A | N-ferrocenyl (benzoyl)-phenylalanine methyl ester bonded silica gel stationary phase as well as preparation method and application thereof | UNIV ZHENGZHOU | 2014-04-16 | — | — | CN | disclosed |
| EP-1840116-B1 | PROCESS FOR PRODUCING OPTICALLY ACTIVE BETA-HYDROXY-ALPHA-AMINOCARBOXYLIC ACID DERIVATIVE | NISSAN CHEMICAL IND LTD (JP) | 2012-10-03 | — | — | EP | disclosed |
| US-5532395-A | HYDROGENATION CATALYSTS ) | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 1996-07-02 | — | — | US | disclosed |
| US-5386061-A | Reacting a bis(primary phosphine in the presence of a strong base with a cyclic sulfate; cyclization | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 1995-01-31 | — | — | US | disclosed |
| US-5329015-A | Catalysts for stereospecific reactions | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 1994-07-12 | — | — | US | disclosed |
| EP-0592552-A1 | CHIRAL PHOSPHOLANES VIA CHIRAL 1,4-DIOL CYCLIC SULFATES. | DU PONT (US) | 1994-04-20 | — | — | EP | disclosed |
| WO-1993001199-A1 | CHIRAL PHOSPHOLANES VIA CHIRAL 1,4-DIOL CYCLIC SULFATES | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 1993-01-21 | — | — | WO | disclosed |
| US-5171892-A | Chiral phospholanes via chiral 1,4-diol cyclic sulfates | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 1992-12-15 | — | — | US | disclosed |
| EP-0145265-B1 | ALPHA-AMINO ACIDS THROUGH CATALYTIC REACTION OF CO AND A HYDROXYL COMPOUND WITH ENAMIDES | THE STANDARD OIL COMPANY (US) | 1989-09-20 | — | — | EP | disclosed |
| US-4749786-A | α-amino acids through catalytic reaction of CO and a hydroxyl compound with enamides | THE STANDARD OIL COMPANY (US) | 1988-06-07 | — | — | US | disclosed |
| US-4710574-A | HYDROCARBOXYLATION OF UNSATURATED AMIDES | THE STANDARD OIL COMPANY (US) | 1987-12-01 | — | — | US | disclosed |
| EP-0145265-A2 | Alpha-amino acids through catalytic reaction of CO and a hydroxyl compound with enamides | THE STANDARD OIL COMPANY (US) | 1985-06-19 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230040081-A1 | VACCINIA VIRAL POLYMERASE-MEDIATED VIRAL REPLICATION | POLR1G, POLR1A, POLR1E | GAA 2118/4885RAB9A 2866/4885ALDH1A1 4620/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.